ReviewLancet Oncol2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
- Journal
- Lancet Oncol
- Published
- 6 May 2016
- Citations
- 723
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- BackgroundConcurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer NCT05262452↗
- BackgroundSequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With… NCT04570943↗
- BackgroundSplit-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer NCT04289792↗